Sugi Predict

Sugi Predict / Compounds / SCHEMBL4565080

SCHEMBL4565080

SCHEMBL4565080

CC(=O)NC(C)(C)CC(C1CCN(C(=O)OC(C)(C)C)CC1)C1CCC(F)(F)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 8/20 0.39
▸ DPP4 P27487 2/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ EPHX1 P07099 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ EPHX2 P34913 2/20 0.35
▸ IDH1 O75874 2/20 0.35
▸ IDH2 P48735 1/20 0.35
▸ EED O75530 1/20 0.35
▸ RBBP4 Q09028 1/20 0.35
▸ SUZ12 Q15022 1/20 0.35
▸ EZH2 Q15910 1/20 0.35
▸ AEBP2 Q6ZN18 1/20 0.35
▸ MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4466332 0.86 DPP4 (0.42) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL2940070 0.79 DPP4 (0.40) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL13316272 0.76 EPHX1 (0.42) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL2940071 0.69 EPHX1 (0.48) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL13630786 0.69 EPHX1 (0.48) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL1059936 0.69 GPR119 (0.41) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL1059411 0.69 GPR119 (0.41) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL1059933 0.69 GPR119 (0.41) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL1059934 0.69 GPR119 (0.41) GPR119DPP4NPC1ALDH1A1MAPT
SCHEMBL2258037 0.68 DPP4 (0.54) GPR119DPP4NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773338-B1 ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS MERCK & CO INC (US) 2010-01-06 — — EP disclosed
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 — — US disclosed
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 — — US disclosed
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 — — US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 — — US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 — — US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MC4R, MC5R, MC3R GPR119 12/4885DPP4 138/4885NPC1 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.